Literature DB >> 11301066

Nicotine-induced behavioral disinhibition and ethanol preference correlate after repeated nicotine treatment.

P Olausson1, M Ericson, E Löf, J A Engel, B Söderpalm.   

Abstract

This study investigated the effects of repeated daily nicotine (0.35 mg/kg; 15 days) treatment on behavioral inhibition and locomotor activity in the elevated plus-maze and on voluntary ethanol consumption. When challenged with nicotine before the test, rats pretreated with repeated nicotine spent more time on and made more entries onto the open arms of an elevated plus-maze than did vehicle-pretreated animals. The ethanol preference and intake, measured during 3 h after a nicotine injection, was also higher in the nicotine-pretreated animals. In ethanol consumption experiments, there was a positive correlation between the % time and % entries made onto open arms vs. the ethanol preference and intake. However, no correlation between the total number of entries made in the elevated plus-maze and the measures of ethanol consumption was observed. These findings suggest that the ability of repeated nicotine administration to increase ethanol consumption is related to development of a nicotine-induced reduction of inhibitory control rather than development of locomotor sensitization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301066     DOI: 10.1016/s0014-2999(01)00903-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  25 in total

1.  Chronic nicotine activates stress/reward-related brain regions and facilitates the transition to compulsive alcohol drinking.

Authors:  Rodrigo M Leão; Fábio C Cruz; Leandro F Vendruscolo; Giordano de Guglielmo; Marian L Logrip; Cleopatra S Planeta; Bruce T Hope; George F Koob; Olivier George
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

2.  Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time-dependent manner.

Authors:  Sheketha R Hauser; Bruk Getachew; Scott M Oster; Ronnie Dhaher; Zheng-Ming Ding; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Alcohol Clin Exp Res       Date:  2011-06-20       Impact factor: 3.455

Review 3.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

4.  Nicotine and ethanol co-use in Long-Evans rats: Stimulatory effects of perinatal exposure to a fat-rich diet.

Authors:  Olga Karatayev; Olga Lukatskaya; Sang-Ho Moon; Wei-Ran Guo; Dan Chen; Diane Algava; Susan Abedi; Sarah F Leibowitz
Journal:  Alcohol       Date:  2015-04-11       Impact factor: 2.405

5.  Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse.

Authors:  A D Lê; Douglas Funk; Steven Lo; Kathleen Coen
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

Review 6.  Interactions between nicotine and drugs of abuse: a review of preclinical findings.

Authors:  Stephen J Kohut
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-02       Impact factor: 3.829

7.  Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats.

Authors:  A D Lê; A Wang; S Harding; W Juzytsch; Y Shaham
Journal:  Psychopharmacology (Berl)       Date:  2003-01-21       Impact factor: 4.530

8.  Coadministration of intravenous nicotine and oral alcohol in rats.

Authors:  A D Lê; Steven Lo; Stephen Harding; Walter Juzytsch; Peter W Marinelli; Douglas Funk
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

Review 9.  The genetic components of alcohol and nicotine co-addiction: from genes to behavior.

Authors:  Isabel R Schlaepfer; Nicole R Hoft; Marissa A Ehringer
Journal:  Curr Drug Abuse Rev       Date:  2008-06

10.  Common effects of fat, ethanol, and nicotine on enkephalin in discrete areas of the brain.

Authors:  G-Q Chang; O Karatayev; J R Barson; S C Liang; S F Leibowitz
Journal:  Neuroscience       Date:  2014-07-30       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.